Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discovery.
Alzheimer's disease (AD) is characterized by the aggregation of amyloid β (Aβ) peptides and the formation of plaques in the brain, primarily derived from the proteolytic degradation of amyloid precursor protein (APP). Cathepsin B (CatB) is a cysteine protease that plays a pivotal role in this p...
Saved in:
| Main Authors: | Mohammed Alrouji, Sabina Yasmin, Mohammed S Alshammari, Fahad A Alhumaydhi, Sharaf E Sharaf, Moyad Shahwan, Anas Shamsi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0316010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions
by: Mohammed Alrouji, et al.
Published: (2024-11-01) -
Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations
by: Mohd Shahnawaz Khan, et al.
Published: (2025-08-01) -
Identification of potential inhibitors of Ubiquitin carboxyl-terminal hydrolase 21 from repurposed drugs: Implications in anticancer therapeutics
by: Anas Shamsi, et al.
Published: (2025-06-01) -
Structure-guided drug repurposing identifies aristospan as a potential inhibitor of β-lactamase: insights from virtual screening and molecular dynamics simulations
by: Moyad Shahwan, et al.
Published: (2024-11-01) -
Unraveling human transferrin-tryptamine interactions: a computational and biophysical approach to Alzheimer’s disease therapeutics
by: Mohammed Alrouji, et al.
Published: (2025-03-01)